Evogene Ltd. (EVGN) Tops Q1 EPS by 7c

Evogene Ltd. (NYSE: EVGN) reported Q1 EPS of ($0.13), $0.07 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.65 million.

For earnings history and earnings-related data on Evogene Ltd. (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c